You are here
Articles
Posted on Thursday, September 13, 2012 - 12:01pm
'Your Blood'
An independent supplement distributed by the Guardian on behalf of MediaPlanet who take sole responsibility for its contents.
Posted on Monday, September 10, 2012 - 5:20pm
In April 2013 the annual European Group for Blood and Marrow Transplantation (EBMT) conference will be held in London. As part of this conference, there is a dedicated Patient and Family Day on Saturday 6 April where...
Posted on Monday, September 10, 2012 - 1:50pm
Phase 2 Study of Subcutaneous Omacetaxine Mepesuccinate After TKI Failure in Patients With Chronic-Phase CML With T315I Mutation
Blood. 2012 Aug 15;[Epub Ahead of Print], J Cortes, JH Lipton, D Rea, R Digumarti, C Chuah...
Posted on Monday, September 10, 2012 - 1:47pm
With an FDA filing of its wholly owned chronic myelogenous leukemia drug ponatinib under its belt, Ariad Pharmaceuticals Inc.says it will be commercially ready in the U.S. by the end of October and hopes to launch in...
Posted on Monday, September 10, 2012 - 1:36pm
Contrasting Effects of Diclofenac and Ibuprofen on Active Imatinib Uptake Into Leukaemic Cells
Br J Cancer. 2012 May 1;1061772-1778, J Wang, TP Hughes,
Posted on Tuesday, August 21, 2012 - 11:28am
Thanks to Andrew Schorr of Patient Power who produced the following video interview with Brian Druker MD.
Posted on Thursday, August 16, 2012 - 4:29pm
'Results from the ongoing Phase 2 PACE trial of ponatinib reported in June at this year’s annual meeting of the American Society of Clinical Oncology showed that 54 percent of chronic-phase CML patients who were...
Posted on Monday, July 30, 2012 - 5:44pm
New Data Confirm Safety of Stopping Imatinib in Leukemia
IMNG Medical Media. 2012 Jun 26, S Freeman
Posted on Monday, July 30, 2012 - 11:42am
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 27, 2012--
Posted on Friday, July 6, 2012 - 2:15pm
Leukemia. 2012 Mar 26. doi: 10.1038/leu.2012.85. [Epub ahead of print]
Posted on Tuesday, July 3, 2012 - 5:55pm
Leukemia advance online publication
15 June 2012; doi: 10.1038/leu.2012.134
Posted on Tuesday, July 3, 2012 - 4:14pm
New Data Confirm Safety of Stopping Imatinib in Leukemia
IMNG Medical Media. 2012 Jun 26, S Freeman
Posted on Monday, June 25, 2012 - 7:13pm
Ho-Young Yhim, Na-Ri Lee, Eun-Kee Song, Chang-Yeol Yim, So Yeon Jeon, Seunghwan Shin, Jeong-A Kim, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak
Division of Hematology/Oncology, Department of Internal Medicine, Republic of...
Posted on Monday, June 11, 2012 - 3:46pm
PACE: Robust and Durable Antileukemic Responses With Ponatinib in Patients With Heavily Pretreated, Refractory CML or Ph+ ALL
Posting Date: June 06, 2012
Updated analysis of PACE: single-arm phase II trial[1]
Summary of...
Posted on Saturday, May 26, 2012 - 7:28pm
Critical Reviews in Oncology/Hematology
Javier Pinilla-Ibarz, Ian Flinn -
published online 09 April 2012.
- ‹ previous
- 18 of 33
- next ›